Financial Performance - Q3 FY25 net sales were 53.8million,a2.752.4 million in Q3 FY24[4] - Year-to-date net sales for the first nine months of FY25 were 157.0million,a5.3149.1 million in the same period of FY24[17] - Net sales for the three months ended March 1, 2025, were 53,804thousand,representinga2.752,375 thousand for the same period in 2024[37] - The PMT segment saw a 6.6% increase in net sales to 33,216thousandforthethreemonthsendedMarch1,2025,whiletheGESsegmentexperienceda19.49,299 thousand[37] - The healthcare segment's net sales decreased by 32.3% to 2,094thousandforthethreemonthsendedMarch1,2025[37]Profitability−Non−GAAPoperatingincomeforQ3FY25roseto2.2 million, up from 1.0millionintheprioryear[3]−Non−GAAPnetincomeforthethreemonthsendedMarch1,2025,was1,581 thousand compared to 750thousandinthesameperiodlastyear[39]−Non−GAAPEarningsPerCommonShare(Diluted)forthethreemonthsendedMarch1,2025,was0.11, up from 0.05inthesameperiodof2024[21]−AdjustedEBITDAforthethreemonthsendedMarch1,2025,was2,806,000, compared to 2,083,000forthesameperiodin2024,indicatinggrowth[22]−Thecompanyreportedanetlossof2.1 million for Q3 FY25, compared to a net income of 0.8millioninQ3FY24[12]−Thecompanyreportedanetlossof2,057 thousand for the three months ended March 1, 2025, compared to a net income of 750thousandforthesameperiodin2024[35]−Thecompanyreportedacomprehensivelossof(2,759) thousand for the three months ended March 1, 2025, compared to a comprehensive income of 545thousandforthesameperiodin2024[35]ExpensesandLiabilities−Operatingexpenseswere14.5 million, slightly up from 14.4millioninQ3FY24[8]−TotalliabilitiesasofMarch1,2025,were36,910,000, compared to 34,493,000onJune1,2024,showinganincrease[31]−DepreciationandamortizationexpensesfortheninemonthsendedMarch1,2025,totaled3,037 million, down from 3,218millionforthesameperiodin2024[40]CashandAssets−ThecompanyendedQ3FY25with36.7 million in cash and equivalents, with no debt[2] - Cash and cash equivalents increased to 36,675,000asofMarch1,2025,from24,263,000 on June 1, 2024[31] - Total current assets as of March 1, 2025, were 163,514,000,slightlyupfrom161,654,000 on June 1, 2024[31] - The company’s total assets decreased to 189,810,000asofMarch1,2025,from192,445,000 on June 1, 2024[31] - The company’s retained earnings decreased to 79,117,000asofMarch1,2025,from83,729,000 on June 1, 2024[31] Future Outlook - The company plans to host a conference call on April 10, 2025, to discuss its third quarter fiscal-year 2025 results[25] - The company declared a quarterly cash dividend of 0.06pershare,payableonMay28,2025[18]AdjustedMetrics−TheadjustedEBITDAfortheninemonthsendedMarch1,2025,was4,458 million, an increase from 3,514millionforthesameperiodin2024[40]−TheadjustedEBITDAforthethreemonthsendedMarch1,2025,was2,806 million, an increase from 2,083millionforthesameperiodin2024[40]−ThecompanyreportedadecreaseinEBITDAfortheninemonthsendedMarch1,2025,to(458) million from $3,514 million for the same period in 2024[40]